Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:08 pm Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Palo Alto Investors LP | 2,834,244 5.090% | -1,396,304 (-33.01%) | Filing History |
| 2022-02-14 11:15 am Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Macquarie Group Limited | 2,913,471 5.230% | -278,563 (-8.73%) | Filing History |
| 2022-02-11 9:12 pm Purchase | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | STATE STREET CORP STT | 3,327,433 5.970% | 123,529 (+3.86%) | Filing History |
| 2022-02-11 3:57 pm Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Renaissance Technologies LLC | 3,212,214 5.770% | -778,189 (-19.50%) | Filing History |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | The Vanguard Group | 3,876,684 6.960% | -82,396 (-2.08%) | Filing History |
| 2022-01-27 5:14 pm Unchanged | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,825,375 17.600% | 0 (Unchanged) | Filing History |
| 2022-01-26 09:17 am Purchase | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | BlackRock Inc. BLK | 9,825,375 17.600% | 10,778 (+0.11%) | Filing History |